Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Vaccine|August 18, 2006
Shielding of immunogenic domains in Neisseria meningitidis FrpB (FetA) by the major variable regionJeroen Kortekaas, Annika Pettersson, Jenny van der Biezen, et al.
Infectious Diseases and Therapy|February 8, 2025
Economic and Disease Burden Associated with Invasive Escherichia coli Disease in the United StatesMark A Schmidt, Maxim Blum, Judy L Donald, et al.
Journal of Medical Microbiology|July 10, 2010
Presence of capsular locus genes in immunochemically identified encapsulated and unencapsulated Streptococcus pneumoniae sputum isolates obtained from elderly patients with acute lower respiratory tract infectionPaula Kurola, Leena Erkkilä, Tarja Kaijalainen, et al.
Lancet (London, England)|March 7, 2006
Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy studyRoman Prymula, Pascal Peeters, Viktor Chrobok, et al.
Open Forum Infectious Diseases|August 23, 2023
Safety, Reactogenicity, Immunogenicity, and Dose Selection of 10-Valent Extraintestinal Pathogenic Escherichia coli Bioconjugate Vaccine (VAC52416) in Adults Aged 60-85 Years in a Randomized, Multicenter, Interventional, First-in-Human, Phase 1/2a StudyCarlos A Fierro, Michal Sarnecki, Joachim Doua, et al.
NPJ Vaccines|June 14, 2024
A randomized phase 1/2a trial of ExPEC10V vaccine in adults with a history of UTICarlos A Fierro, Michal Sarnecki, Bart Spiessens, et al.
Epidemiology and Infection|January 6, 2025
Epidemiology of invasive Escherichia coli disease in adults in England, 2013-2017Maxim Blum, Jeroen Geurtsen, Eva Herweijer, et al.
Human Vaccines & Immunotherapeutics|May 18, 2018
Safety, tolerability and immunogenicity of the ExPEC4V (JNJ-63871860) vaccine for prevention of invasive extraintestinal pathogenic Escherichia coli disease: A phase 1, randomized, double-blind, placebo-controlled study in healthy Japanese participantsMegumi Inoue, Tetsuro Ogawa, Hiroshi Tamura, et al.
The Lancet. Infectious Diseases|May 14, 2019
Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trialRobert W Frenck, John Ervin, Laurence Chu, et al.
The Journal of Urology|October 20, 2020
Epidemiology and O-Serotypes of Extraintestinal Pathogenic Escherichia coli Disease in Patients Undergoing Transrectal Ultrasound Prostate Biopsy: A Prospective Multicenter StudySteven Rosenberg, Marc Bonten, Wouter Haazen, et al.
Pageof 6